Impact of melphalan dose during reduced‐intensity conditioning on engraftment of cord blood transplantation for chronic Epstein‐Barr virus‐associated T or NK cell lymphoproliferative diseases-Reference-Cited by-同舟云学术

Impact of melphalan dose during reduced‐intensity conditioning on engraftment of cord blood transplantation for chronic Epstein‐Barr virus‐associated T or NK cell lymphoproliferative diseases

Published:2020-06-21 Issue:9 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Mayumi Azusa¹^ORCID,Sawada Akihisa¹,Sato Maho¹,Shimizu Mariko¹,Ioi Aya¹,Higuchi Kohei¹,Yasui Masahiro¹,Kawa Keisei¹,Inoue Masami¹

Affiliation:

1. Department of Hematology/Oncology Osaka Women's and Children's Hospital Osaka Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28536

Reference8 articles.

1. Diagnosis and treatment of epstein-barr virus-associated natural killer cell lymphoproliferative disease

2. EBV-associated T/NK–cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases

3. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

4. Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development

5. How I treat T-cell chronic active Epstein-Barr virus disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unrelated cord blood transplantation for adult-onset EBV-associated T-cell and NK-cell lymphoproliferative disorders;International Journal of Hematology;2022-03-10

2. Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children;International Journal of Hematology;2021-11-05

3. Methotrexate/tacrolimus;Reactions Weekly;2021-02